Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 390-397

  Cho, Kwan Ho ^a   Kim, Joo Young ^a   Lee, Seung Hoon ^a   Yoo, Heon ^a   Shin, Sang Hoon ^a   Moon, Sung Ho ^a   Kim, Tae Hyun ^a   Shin, Kyung Hwan ^a   Yoon, Myonggeun ^a   Lee, Doo Hyun ^a   Pyo, Hong Ryull ^a  

^a National Cancer Center   (South Korea)

Author keywords

Glioma; Intensity modulated radiotherapy; Patterns of failure; Simultaneous integrated boost; Survival; Toxicity

Indexed keywords

CHEMOTHERAPY; RADIOTHERAPY; TOXICITY; TUMORS;

GLIOMA; INTENSITY-MODULATED RADIOTHERAPY; PATTERNS OF FAILURE; SIMULTANEOUS INTEGRATED BOOSTS; SURVIVAL;

PHYSICAL THERAPY;

CISPLATIN; NIMUSTINE; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTIPLE CYCLE TREATMENT; OLIGODENDROGLIOMA; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; TREATMENT FAILURE; TUMOR RECURRENCE; TUMOR VOLUME; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN NEOPLASMS; DACARBAZINE; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 77956512228     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.029     Document Type: Article

References (20)

1. L.G. Salford, A. Brun, and S. Nirfalk Ten-year survival among patients with supratentorial astrocytoma grade III and IV J Neurosurg 69 1988 506 509
2. K.E. Wallner, J.H. Galicich, G. Krol, E. Arbit, and M.G. Malkin Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma Int J Radiat Oncol Biol Phys 16 1989 1405 1409
3. M.D. Prados, W.M. Wara, and P.K. Sneed Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme Int J Radiat Oncol Biol Phys 49 2001 71 77
4. C. Nieder, N. Andratschke, N. Wiedenmann, R. Busch, A.L. Grosu, and M. Molls Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 180 2004 401 407
5. R.G. Selker, W.R. Shapiro, and P. Burger The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine Neurosurg 51 2002 343 355
6. L. Souhami, W. Seiferheld, and D. Brachman Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol Int J Radiat Oncol Biol Phys 60 2004 853 860
7. M.F. Chan, K. Schupak, C. Burman, C.S. Chui, and C.C. Ling Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme Med Dosim 28 2003 261 265
8. S.M. MacDonald, S. Ahmad, and S. Kachris Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison J Appl Clin Med Phys 8 2007 47 60
9. U. Hermanto, E.K. Frija, M.J. Lii, E.L. Chang, A. Mahajan, and S.Y. Woo Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: Does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67 2007 1135 1144
10. C. Thilmann, A. Zabel, K.H. Grosser, A. Hoess, M. Wannenmacher, and J. Debus Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas Int J Cancer 96 2001 341 349
11. W.J. Curran Jr., C.B. Scott, and J. Horton Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
12. W.S. Koom, T.H. Kim, and K.H. Shin SMART (Simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas Head Neck 30 2008 159 169
13. K.H. Cho, S.J. Ahn, and H.R. Pyo A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable stage III non-small-cell lung cancer: Results of Korean Radiation Oncology Group 0301 study Int J Radiat Oncol Biol Phys 74 2009 1397 1404
14. K. Sultanem, H. Patrocinio, and C. Lambert The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial Int J Radiat Oncol Biol Phys 58 2004 247 252
15. T. Iuchi, K. Hatano, Y. Narita, T. Kodama, T. Yamaki, and K. Osato Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT Int J Radiat Oncol Biol Phys 64 2006 1317 1324
16. K. Nakamatsu, M. Suzuki, and Y. Nishimura Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant glioma using intensity-modulated radiotherapy Int J Clin Oncol 13 2008 48 53
17. V. Panet-Raymond, L. Souhami, and D. Roberge Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: A safety and efficacy analysis Int J Radiat Oncol Biol Phys 73 2009 473 478
18. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
19. M.E. Hegi, A.-C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
20. R. Stupp, M.E. Hegi, and W.P. Mason Effect of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466